FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) Ciprofloxacin Tablets Recall

CIPROFLOXACIN TABLETS, USP, 500 mg, 100 Tablets (10 tablets per blister card

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) · Rockford, IL

Risk level
Class II
Reported by FDA
Jan 28, 2015
Recall ID
D-0377-2015
Check your lot numberHow we source this data

Summary

Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalled Ciprofloxacin Tablets starting Sep 26, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0377-2015 on Jan 28, 2015. Reason: CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices. Status: Terminated.

Why it was recalled

CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices

Product description

CIPROFLOXACIN TABLETS, USP, 500 mg, 100 Tablets (10 tablets per blister card. 10 blister cards per carton), Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV --- NDC 51079-182-20.

Lot numbers, UPCs & expiration codes

Lot Number: 3034630; Expiration Date: 12/13; NDC: 51079-182-20

Where it was sold

Nationwide and Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0377-2015
Classification
Class II
Status
Terminated
Recall initiated
Sep 26, 2013
FDA report date
Jan 28, 2015
Quantity
11,650 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Original FDA data

Every field from FDA enforcement report D-0377-2015, exactly as published.

Show all FDA fields
City
Rockford
State
IL
Status
Terminated
Country
United States
Event ID
66607
Address
1718 Northrock Ct
Code information
Lot Number: 3034630; Expiration Date: 12/13; NDC: 51079-182-20
Postal code
61103-1201
Report date
Jan 28, 2015
Product type
Drugs
Recall number
D-0377-2015
Classification
Class II
Recalling firm
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
Product quantity
11,650 cartons
Termination date
Nov 9, 2015
Reason for recall
CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices
Voluntary / mandated
Voluntary: Firm initiated
Product description
CIPROFLOXACIN TABLETS, USP, 500 mg, 100 Tablets (10 tablets per blister card. 10 blister cards per carton), Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV --- NDC 51079-182-20.
Distribution pattern
Nationwide and Puerto Rico.
Recall initiation date
Sep 26, 2013
Initial firm notification
Letter
Center classification date
Jan 21, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0377-2015, published Jan 28, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls